---
figid: PMC4712330__aging-07-1032-g004
figlink: /pmc/articles/PMC4712330/figure/F4/
number: F4
caption: PTEN deficiency is associated with increased sensitivity to PI3K, AKT, and
  mTOR inhibitors. In addition, because PI3K is involved in BCR signaling activation,
  BCR pathway inhibitors may also be effective in PTEN-deficient lymphoid malignancies.
  SRC family kinase inhibitors include dasatinib (which can also inhibit BTK), saracatinib,
  bosutinib, SU6656, CGP76030, and KX-01. BTK inhibitors include ibrutinib and AVL-292.
  Sotrastaurin is a PKCβ inhibitor; A20, a MALT1 paracaspase inhibitor; and MLN120B,
  an IKKβ inhibitor. SYK inhibitors include fostamatinib and PRT062607. Idelalisib
  is a PI3Kδ-specific inhibitor. MK-2206 is an AKT inhibitor. mTOR inhibitors include
  everolimus and temsirolimus.
pmcid: PMC4712330
papertitle: The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
reftext: Xiaoxiao Wang, et al. Aging (Albany NY). 2015 Dec;7(12):1032-1049.
pmc_ranked_result_index: '112628'
pathway_score: 0.9589238
filename: aging-07-1032-g004.jpg
figtitle: PTEN tumor suppressor gene and its role in lymphoma pathogenesis
year: '2015'
organisms: Homo sapiens
ndex: b733c647-dee2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4712330__aging-07-1032-g004.html
  '@type': Dataset
  description: PTEN deficiency is associated with increased sensitivity to PI3K, AKT,
    and mTOR inhibitors. In addition, because PI3K is involved in BCR signaling activation,
    BCR pathway inhibitors may also be effective in PTEN-deficient lymphoid malignancies.
    SRC family kinase inhibitors include dasatinib (which can also inhibit BTK), saracatinib,
    bosutinib, SU6656, CGP76030, and KX-01. BTK inhibitors include ibrutinib and AVL-292.
    Sotrastaurin is a PKCβ inhibitor; A20, a MALT1 paracaspase inhibitor; and MLN120B,
    an IKKβ inhibitor. SYK inhibitors include fostamatinib and PRT062607. Idelalisib
    is a PI3Kδ-specific inhibitor. MK-2206 is an AKT inhibitor. mTOR inhibitors include
    everolimus and temsirolimus.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IKBKB
  - CHUK
  - TNFAIP3
  - BMX
  - IKBKG
  - PIK3R4
  - AKT3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - SYK
  - PRKD3
  - PRKCA
  - MTOR
  - NFKB1
  - PDK1
  - AKT1
  - AKT2
  - PIK3CA
  - PTEN
  - CD19
  - PRKCQ
  - INPP5D
  - PRKCD
  - PRKCE
  - PIK3R6
  - PRKCB
  - BCL10
  - CARD11
  - PRKCZ
  - PIK3R5
  - PRKCG
  - PRKCI
  - PRKCH
  - Bosutinib
  - CGP76030
  - Saracatinib
  - Fostamatinib
  - Sotrastaurin
  - MK-2206
  - Ibrutinib
  - PRT062607
  - Cancer
genes:
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: ETK
  symbol: ETK
  source: hgnc_alias_symbol
  hgnc_symbol: BMX
  entrez: '660'
- word: IKK.
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CD19
  symbol: CD19
  source: hgnc_symbol
  hgnc_symbol: CD19
  entrez: '930'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: SHIP-1
  symbol: SHIP1
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5D
  entrez: '3635'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: BCL-10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: CARD11)
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
chemicals:
- word: Bosutinib
  source: MESH
  identifier: C471992
- word: CGP76030
  source: MESH
  identifier: C472714
- word: Saracatinib
  source: MESH
  identifier: C515233
- word: Fostamatinib
  source: MESH
  identifier: C523665
- word: Sotrastaurin
  source: MESH
  identifier: C543528
- word: MK-2206
  source: MESH
  identifier: C548887
- word: Ibrutinib
  source: MESH
  identifier: C551803
- word: PRT062607
  source: MESH
  identifier: C571149
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4712330__F4
redirect_from: /figures/PMC4712330__F4
figtype: Figure
---
